Morepen Laboratories gains 2.3% after U.S. FDA filing for Sitagliptin tablets
The drugmaker said it submitted its first Abbreviated New Drug Application for Sitagliptin Tablets USP in three strengths.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.